Complex role of chemokine mediators in animal models of Alzheimer's Disease.

about

For better or worse: Immune system involvement in Alzheimer's Disease.Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease

P2860

Q53513308-E4374D02-D5B0-45DB-A12A-59C83F64FDBD Q58758801-2034C203-A8E0-488E-980E-FA2E70EB4023

P2860

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q52315330

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@en

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@nl

type

Item

label

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@en

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@nl

prefLabel

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@en

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

@nl

P1476

Complex role of chemokine mediators in animal models of Alzheimer's Disease

@en

P2093

Elodie Martin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity

TREM2 Variants in Alzheimer's Disease

A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease

International union of pharmacology. XXII. Nomenclature for chemokine receptors

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

Control of microglial neurotoxicity by the fractalkine receptor

Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

P304

34-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJ.2018.01.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Delarasse

P5008

ScienceSource

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29673550

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

peptide

biomedical investigative technique

P932

6138613

http://www.w3.org/2001/XMLSchema#string

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

about

P2860

P2860

Complex role of chemokine mediators in animal models of Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932